BioCentury
ARTICLE | Company News

Agendia sales and marketing update

September 8, 2008 7:00 AM UTC

Agendia launched its TargetPrint breast cancer prognostic test in the U.S. to identify patients likely to benefit from hormone treatments after surgery. The test measures gene expression levels of th...